Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Briacell dropping 30% after FASTTRACK

<< Previous

Bullboard Posts

Next >>

Comment by skier59on Apr 14, 2022 11:14pm

141 Views

Post# 34605930

RE:RE:RE:RE:RE:RE:Briacell dropping 30% after FASTTRACK

I clearly agree with all of this, and can see easily why investors were and are confused. We are lucky to have knowledgeable Shareholders posting here explaining the details, but for the common folks, it was and is confusing, in the manner it is reported. It's the "pending" aspect which completely squews the percentages, drawing a negative conclusion, and such response from the ilinformed.

enriquesuave wrote:
They clearly stated very positive Evaluable CR rates and Specified that there is still a lot of data pending which may or may not support trend. They cannot make up stuff. Data is very good and has improved . We shall see if trend continues by the next readout. Possibly some updates in about 2 weeks ER/ Quarterly?

Rumpl3StiltSkin wrote: Well FGP,

Looking at the title of this message, I guess TLT is in good company, if attaining FT status caused briacell to sell off 30%.... Maybe the whole thing is just 'sell the news'. I don't blame management for this one, they seemed to have tried hard with the roll out of these numbers.

FGPstock wrote:
@999, I don't believe anyone was upset with the results, but more the way the results were announced in which TLT has full control over. Also, I think it has been a pattern for tlt to make statements which cause you to have more questions than answers. When you announce CR's in regards to 80, 180 and 360 days, to most investors seeing 3 or 5% CR after 360 days is horrible, but you need to factor only X percent are even past 360 days which make he results a lot better. I think a lot of us just want transparency. THere are some posters on this board which made it sound like 100% CR was locked in and announcing 30, 60, 90 day results was meaningless. We are not close to 100%, but a lot better than the currentl SOC. I believe the selloff you saw was due to the confusion of the NR. It is not hard to release the facts in a laymens terms, it is beneficial to investors, trial participants, etc. Not a lot to ask from a public company, imo.